Cephalosporins Should Be the Preferred Oral Antibiotics for Empiric Treatment of Outpatient Acute Pyelonephritis
When treating an outpatient suspected of pyelonephritis, consider using a cephalosporin orally as your first-line agent unless local resistance patterns strongly favor otherwise. While fluoroquinolones and TMP-SMX remain options, this shift emphasizes broader spectrum coverage with potentially better stewardship profiles for initial empiric management.
This article provides a focused update on the optimal empiric antibiotic choice for managing acute pyelonephritis in the outpatient setting, which is a common and potentially serious ED presentation requiring prompt coverage to prevent complications like sepsis or renal injury. While fluoroquinolones and TMP-SMX have historically been standard recommendations from various consensus guidelines, this review suggests that cephalosporins may now represent the preferred oral antibiotic class for initial empiric therapy. The core goal remains balancing effective pathogen coverage with robust antimicrobial stewardship principles.